3,4-dihydro-5-methyl-1(2h)-isoquinolinone has been researched along with cyclo(alanylalanyl) in 1 studies
Studies (3,4-dihydro-5-methyl-1(2h)-isoquinolinone) | Trials (3,4-dihydro-5-methyl-1(2h)-isoquinolinone) | Recent Studies (post-2010) (3,4-dihydro-5-methyl-1(2h)-isoquinolinone) | Studies (cyclo(alanylalanyl)) | Trials (cyclo(alanylalanyl)) | Recent Studies (post-2010) (cyclo(alanylalanyl)) |
---|---|---|---|---|---|
16 | 0 | 2 | 5 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jain, PG; Patel, BD | 1 |
1 review(s) available for 3,4-dihydro-5-methyl-1(2h)-isoquinolinone and cyclo(alanylalanyl)
Article | Year |
---|---|
Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Humans; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Structure-Activity Relationship | 2019 |